Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

Cited by (970)

Items 401–500 of 970

  1. Neuronal spreading and plaque induction of intracellular Aβ and its disruption of Aβ homeostasis
    Tomas T. Roos, Megg G. Garcia, Isak Martinsson, Rana Mabrouk, Bodil Israelsson, Tomas Deierborg, Asgeir Kobro‐Flatmoen, Heikki Tanila, Gunnar K. Gouras · 2021 · Acta Neuropathologica
  2. The role of amyloidogenic protein oligomerization in neurodegenerative disease
    Gregor P. Lotz, Justin A. Legleiter · 2013 · Journal of Molecular Medicine
  3. Titration of biologically active amyloid–β seeds in a transgenic mouse model of Alzheimer's disease
    Rodrigo Morales, Javiera B Bravo-Alegria, Claudia A. Duran-Aniotz, Claudio A. Soto · 2015 · Scientific Reports
  4. Defining the limits: Protein aggregation and toxicityin vivo
    William M. Holmes, Courtney L. Klaips, Tricia R. Serio · 2014 · Critical Reviews in Biochemistry and Molecular Biology
  5. Accelerating progress in induced pluripotent stem cell research for neurological diseases
    Daisuke Ito, Hideyuki Okano, Norihiro Suzuki · 2012 · Annals of Neurology
  6. Flexibility and Solvation of Amyloid-β Hydrophobic Core
    Liliya Vugmeyster, Matthew A. Clark, Isaac Falconer, Dmitry Ostrovsky, Donald Gantz, Wei Qiang, Gina L. Hoatson · 2016 · Journal of Biological Chemistry
  7. Transmission of Neurodegenerative Disorders Through Blood Transfusion
    Gustaf Edgren, Henrik Hjalgrim, Klaus Rostgaard, Paul C. Lambert, Agneta Taune Wikman, Rut Norda, Kjell-Einar Titlestad, Christian Erikstrup, Henrik Ullum, Mads Melbye et al. · 2016 · Annals of Internal Medicine
  8. Intracerebral seeding of amyloid-β and tau pathology in mice: Factors underlying prion-like spreading and comparisons with α-synuclein
    Brendan B. McAllister, Sean G. Lacoursiere, Robert J. Sutherland, Majid H. Mohajerani · 2020 · Neuroscience & Biobehavioral Reviews
  9. Transmission of amyloid-beta and tau pathologies is associated with cognitive impairments in a primate
    Suzanne Lam, Fanny Petit, Anne‐Sophie Hérard, Susana Boluda, Sabiha Eddarkaoui, Martine Guillermier, The Brain Bank Neuro-C. E. B. Neuropathology Network, Franck Letournel, Marie‐Laure Martin‐Négrier, Maxime Faisant et al. · 2021 · Acta Neuropathologica Communications
  10. Heparan Sulfate Subdomains that are Degraded by Sulf Accumulate in Cerebral Amyloid ß Plaques of Alzheimer's Disease
    Tomomi Hosono‐Fukao, Shiori Ohtake‐Niimi, Hitomi Hoshino, Markus Britschgi, Hiroyasu Akatsu, Md. Motarab Hossain, Kazuchika Nishitsuji, Toin H. Van Kuppevelt, Koji Kimata, Makoto Michikawa et al. · 2012 · American Journal Of Pathology
  11. Prion-like propagation of cytosolic protein aggregates
    Carmen I. Nussbaum-Krammer, Hermann M. Schätzl, Ina Maja Vorberg · 2009 · Prion
  12. Specification of Physiologic and Disease States by Distinct Proteins and Protein Conformations
    Daniel F. Jarosz, Vikram Khurana · 2017 · Cell
  13. Diverse Misfolded Conformational Strains and Cross-seeding of Misfolded Proteins Implicated in Neurodegenerative Diseases
    Kwang Hun Lim · 2019 · Frontiers in Molecular Neuroscience
  14. Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid β and the Asn23 Iowa mutation
    Silvia Fossati, Krysti L. Todd, Krystal Sotolongo, Jorge A. Ghiso, Agueda A. Rostagno · 2013 · Biochemical Journal
  15. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease
    Rosen, Rebecca F., Tomidokoro, Yasushi, Farberg, Aaron S., Dooyema, Jeromy, Ciliax, Brian, Preuss, Todd M., Neubert, Thomas A., Ghiso, Jorge A., LeVine, Harry, Walker, Lary C. · 2016 · Neurobiology of Aging
  16. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study
    Tanja Blume, Carola Focke, Finn Peters, Maximilian Deußing, Nathalie L. Albert, Simon Lindner, Franz‐Josef Gildehaus, Barbara von Ungern‐Sternberg, Laurence Ozmen, Karlheinz Baumann et al. · 2018 · Journal of Neuroinflammation
  17. The Role of Antibodies and Their Receptors in Protection Against Ordered Protein Assembly in Neurodegeneration
    Taxiarchis Katsinelos, Benjamin J. Tuck, Aamir S. Mukadam, William A. McEwan · 2019 · Frontiers in Immunology
  18. Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
    Cameron Wells, Samuel E. Brennan, Matthew Keon, Nitin Saksena · 2019 · Frontiers in Molecular Neuroscience
  19. Expanding spectrum of prion diseases
    Jacob I. Ayers, Nick A. Paras, Stanley B. Prusiner · 2020 · Emerging Topics in Life Sciences
  20. TDP ‐43 in amyotrophic lateral sclerosis – is it a prion disease?
    Albert Christian Ludolph, Johannes Brettschneider · 2015 · European Journal of Neurology
  21. Biaryl Amides and Hydrazones as Therapeutics for Prion Disease in Transgenic Mice
    Duo Lü, Kurt Giles, Zhe Li, Satish Rao, Elena Dolghih, Joel R. Gever, Michal Geva, Manuel Elepano, Abby Oehler, Clifford Bryant et al. · 2013 · Journal of Pharmacology and Experimental Therapeutics
  22. Toxic amyloid-β oligomers induced self-replication in astrocytes triggering neuronal injury
    Wei Wang, Tingting Hou, Long-fei Jia, Qiaoqi Wu, Meina Quan, Jianping Jia · 2019 · EBioMedicine
  23. Aggregate-Depleted Brain Fails to Induce Aβ Deposition in a Mouse Model of Alzheimer's Disease
    Claudia A. Duran-Aniotz, Rodrigo Morales, Inés Moreno‐González, Ping Ping Hu, Joseph P. Fedynyshyn, Claudio A. Soto · 2014 · PLoS ONE
  24. Recombinant Prion Protein Refolded with Lipid and RNA Has the Biochemical Hallmarks of a Prion but Lacks In Vivo Infectivity
    Andrew G. Timmes, Roger A. Moore, Elizabeth R. Fischer, Suzette A. Priola · 2013 · PLoS ONE
  25. Initiation and propagation of neurodegeneration
    Christian Haass · 2010 · Nature Medicine
  26. Interneurons in the human olfactory system in Alzheimer's disease
    Daniel Saiz‐Sánchez, Alicia Flores‐Cuadrado, Isabel Úbeda‐Bañón, Carlos de la Rosa‐Prieto, Alino Martı́nez-Marcos · 2015 · Experimental Neurology
  27. In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein
    Farron L. McIntee, Patrizia Giannoni, Steven P. Blais, George Sommer, Thomas A. Neubert, Agueda A. Rostagno, Jorge A. Ghiso · 2016 · Frontiers in Aging Neuroscience
  28. The cellular and pathologic prion protein
    Andrew C. Gill, Andrew R. Castle · 2018 · Handbook of clinical neurology
  29. Aβ Seeding as a Tool to Study Cerebral Amyloidosis and Associated Pathology
    Marina Friesen, Melanie Meyer‐Luehmann · 2019 · Frontiers in Molecular Neuroscience
  30. Making the Brain Glow: In Vivo Bioluminescence Imaging to Study Neurodegeneration
    Katja Hochgräfe, Eva‐Maria Mandelkow · 2012 · Molecular Neurobiology
  31. Modeling the early stages of Alzheimer’s disease by administering intracerebroventricular injections of human native Aβ oligomers to rats
    Eva Anna Marianne Baerends, Katia Soud, Jonas Folke, Anna-Kathrine Pedersen, Simon Henmar, Lisa Konrad, Matthew Domenic Lycas, Yuki Mori, Bente Pakkenberg, David P.D. Woldbye et al. · 2022 · Acta Neuropathologica Communications
  32. Mechanism of Scrapie Prion Precipitation with Phosphotungstate Anions
    Dana J. Levine, Jan Stöhr, Lillian E. Falese, Julian Ollesch, Holger Wille, Stanley B. Prusiner, Jeffrey R. Long · 2014 · ACS Chemical Biology
  33. Vaccination with Aβ-Displaying Virus-Like Particles Reduces Soluble and Insoluble Cerebral Aβ and Lowers Plaque Burden in APP Transgenic Mice
    Patricia Bach, Jakob‐A. Tschäpe, Ferdinand Kopietz, Gundula Braun, Janina K. Baade, Karl‐Heinz Wiederhold, Matthias Staufenbiel, Marco Prinz, Thomas Deller, Ulrich Kalinke et al. · 2009 · The Journal of Immunology
  34. Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice
    Alexandra A. Kulikova, Ivan B. Cheglakov, Michail S. Kukharsky, Ruslan K. Ovchinnikov, Sergey A. Kozin, Alexander А. Makarov · 2016 · Neurotoxicity Research
  35. From Soluble A β to Progressive A β Aggregation: Could Prion‐Like Templated Misfolding Play a Role?
    Yvonne S. Eisele · 2013 · Brain Pathology
  36. Protein engineering to stabilize soluble amyloid β‐protein aggregates for structural and functional studies
    Torleif Härd · 2011 · FEBS Journal
  37. Transcriptional and post‐transcriptional regulation of β‐secretase
    Tamagno, Elena, Guglielmotto, M., Monteleone, D., Vercelli, A., Tabaton, M. · 2012 · IUBMB Life
  38. Formaldehyde-fixed brain tissue from spontaneously ill α-synuclein transgenic mice induces fatal α-synucleinopathy in transgenic hosts
    Manuel Schweighauser, Mehtap Bacioglu, Sarah K. Fritschi, Derya R. Shimshek, Philipp J. Kahle, Yvonne S. Eisele, Mathias Jucker · 2014 · Acta Neuropathologica
  39. Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease
    Yuan Zhao, Yidan Zhang, Jian Zhang, Xiangjian Zhang, Guofeng Yang · 2020 · Current Neuropharmacology
  40. The prion-like phenomenon in Alzheimer’s disease: Evidence of pathology transmission in humans
    Ruben Gomez‐Gutierrez, Rodrigo Morales · 2020 · PLoS Pathogens
  41. Therapeutic approaches for prion and Alzheimer's diseases
    Thomas Wısnıewskı, Einar M. Sigurdsson · 2007 · FEBS Journal
  42. Clustering of plaques contributes to plaque growth in a mouse model of Alzheimer’s disease
    Joanna F McCarter, Sabine Liebscher, Teresa Bachhuber, Claudia Abou‐Ajram, Mark Hübener, Bradley T. Hyman, Christian Haass, Melanie Meyer‐Luehmann · 2013 · Acta Neuropathologica
  43. Anti-amyloid Therapy of Alzheimer’s Disease: Current State and Prospects
    Sergey A. Kozin, Evgeny P. Barykin, Vladimir A. Mitkevich, Alexander А. Makarov · 2018 · Biochemistry (Moscow)
  44. Cerebral hemorrhagic stroke associated with cerebral amyloid angiopathy in young adults about 3 decades after neurosurgeries in their infancy
    Tsuyoshi Hamaguchi, Junji Komatsu, Kenji Sakai, Moeko Noguchi‐Shinohara, Satoshi Aoki, Takeshi Ikeuchi, Masahito Yamada · 2019 · Journal of the Neurological Sciences
  45. Isomerization of Asp7 in Beta-Amyloid Enhances Inhibition of the α7 Nicotinic Receptor and Promotes Neurotoxicity
    E. Barykin, Alexandra I Garifulina, Elena V Kruykova, E. Spirova, A. Anashkina, A. Adzhubei, I. Shelukhina, I. Kasheverov, V. Mitkevich, S. Kozin et al. · 2019 · Cells
  46. Quality Control Compartments Coming of Age
    Tziona Ben‐Gedalya, Ehud Cohen · 2012 · Traffic
  47. Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain
    Sonia Mazzitelli, Fabia Filipello, Marco Rasile, Eliana Lauranzano, Chiara Starvaggi Cucuzza, Matteo Tamborini, Davide Pozzi, Isabella Barajon, Toni Giorgino A, Antonino Natalello et al. · 2016 · Acta Neuropathologica Communications
  48. Prion-like characteristics of the bacterial protein Microcin E492
    Mohammad Shahnawaz, Kyung‐Won Park, Abhisek Mukherjee, Rodrigo Díaz‐Espinoza, Claudio A. Soto · 2017 · Scientific Reports
  49. Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer's disease
    He Liu, Chae Kim, Tracy Haldiman, Christina J. Sigurdson, Sofie Nyström, K. Peter R. Nilsson, Mark L. Cohen, Thomas Wısnıewskı, Per Hammarström, Jiri Safar · 2021 · Journal of Biological Chemistry
  50. Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
    Thomas Wısnıewskı, Allal Boutajangout · 2009 · Brain Structure and Function
  51. Structural differences in amyloid-β fibrils from brains of nondemented elderly individuals and Alzheimer's disease patients
    Ujjayini Ghosh, Wai‐Ming Yau, John Collinge, Robert Tycko · 2021 · Proceedings of the National Academy of Sciences
  52. Opposing effects ofApoe/Apoa1double deletion on amyloid-β pathology and cognitive performance in APP mice
    Nicholas Francis Fitz, Vı́ctor Tapias, Andrea A. Cronican, Emilie L. Castranio, Muzamil Saleem, Alexis Y. Carter, Martina I. Lefterova, Iliya M. Lefterov, Radosveta P. Koldamova · 2015 · Brain
  53. Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease
    Simona Eleuteri, Saviana Di Giovanni, Edward M. Rockenstein, Mike Mante, Antony Adame, Margarita Trejo, Wolf Wrasidlo, Fang Wu, Patrick C. Fraering, Eliezer Masliah et al. · 2014 · Neurobiology of Disease
  54. Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
    Sarah K. Kaufman, Marc I. Diamond · 2013 · Neurotherapeutics
  55. Brains from non-Alzheimer’s individuals containing amyloid deposits accelerate Aβ deposition in vivo
    Claudia A. Duran-Aniotz, Rodrigo Morales, Inés Moreno‐González, Ping Ping Hu, Claudio A. Soto · 2013 · Acta Neuropathologica Communications
  56. Intrinsic Structural Heterogeneity and Long-Term Maturation of Amyloid β Peptide Fibrils
    Jian‐Qiang Ma, Hiroaki Komatsu, Yung Sam Kim, Liu Liu, Robin M. Hochstrasser, Paul H. Axelsen · 2013 · ACS Chemical Neuroscience
  57. Strain-specific Fibril Propagation by an Aβ Dodecamer
    Dexter N. Dean, Pradipta K. Das, Pratip Rana, Franklin Burg, Yona Levites, Sarah E. Morgan, Preetam Ghosh, Vijayaraghavan Rangachari · 2017 · Scientific Reports
  58. Iatrogenic early onset cerebral amyloid angiopathy 30 years after cerebral trauma with neurosurgery: vascular amyloid deposits are made up of both Aβ40 and Aβ42
    Giorgio Giaccone, Emanuela Maderna, Gianluca Marucci, Marcella Catania, Alessandra Erbetta, Luisa Chiapparini, Antonio Indaco, Paola Caroppo, Anna Bersano, Eugenio Agostino Parati et al. · 2019 · Acta Neuropathologica Communications
  59. Evidence of corticofugal tau spreading in patients with frontotemporal dementia
    Eun‐Joo Kim, Jihye Hwang, Stephanie E. Gaus, Alissa L. Nana, Jersey Deng, Jesse A. Brown, Salvatore Spina, Myung Jun Lee, Eliana Marisa Ramos, Lea T. Grinberg et al. · 2019 · Acta Neuropathologica
  60. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Diane L. Ritchie, Marcelo A. Barria · 2021 · Biomolecules
  61. The expanding realm of prion phenomena in neurodegenerative disease
    Bess E Frost, Marc I. Diamond · 2009 · Prion
  62. Evidence for Prion-Like Mechanisms in Several Neurodegenerative Diseases: Potential Implications for Immunotherapy
    Kristen Marciniuk, Ryan Taschuk, Scott Napper · 2013 · Clinical and Developmental Immunology
  63. Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy
    Caroline Sibilla, Anne Bertolotti · 2017 · Cold Spring Harbor Perspectives in Biology
  64. Heterologous Aggregates Promote De Novo Prion Appearance via More than One Mechanism
    Fatih Arslan, Joo Y. Hong, Vydehi Kanneganti, Sei-Kyoung Park, Susan Weiss Liebman · 2015 · PLoS Genetics
  65. Convergent Replication of Mouse Synthetic Prion Strains
    Sina Ghaemmaghami, David W. Colby, Hoang-Oanh B. Nguyen, Shigenari Hayashi, Abby Oehler, Stephen J. DeArmond, Stanley B. Prusiner · 2013 · American Journal Of Pathology
  66. Cellular mechanisms responsible for cell-to-cell spreading of prions
    Didier Vilette, Josquin Courte, Jean‐Michel Peyrin, Laurent Coudert, Laurent Schaeffer, Olivier Andréoletti, Pascal Leblanc · 2018 · Cellular and Molecular Life Sciences
  67. Assessment of the efficacy of different procedures that remove and disassemble alpha-synuclein, tau and A-beta fibrils from laboratory material and surfaces
    Alexis Fenyi, Audrey Coens, Tracy Bellande, Ronald Melki, Luc Bousset · 2018 · Scientific Reports
  68. Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders
    Aurélie de Rus Jacquet, Hélèna L. Denis, Francesca Cicchetti, Melanie Alpaugh · 2021 · Molecular Psychiatry
  69. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis
    Florent Laferrière, Magdalini Polymenidou · 2015 · Swiss Medical Weekly
  70. Dopamine‐induced α‐synuclein oligomers show self‐ and cross‐propagation properties
    Matthew S. Planchard, Sarah E. Exley, Sarah E. Morgan, Vijayaraghavan Rangachari · 2014 · Protein Science
  71. ER stress signaling and neurodegeneration: At the intersection between Alzheimer's disease and Prion-related disorders
    Mauricio Torres, José Manuel Matamala, Claudia A. Duran-Aniotz, Víctor Hugo Cornejo, Andrew Foley, Claudio A. Hetz · 2014 · Virus Research
  72. Cerebral vascular amyloid seeds drive amyloid β-protein fibril assembly with a distinct anti-parallel structure
    Feng Xu, Ziao Fu, Sharmila Dass, AnnMarie E. Kotarba, Judianne Davis, Steven O. Smith, William E. Van Nostrand · 2016 · Nature Communications
  73. Poly-PR in C9ORF72-Related Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Causes Neurotoxicity by Clathrin-Dependent Endocytosis
    Rui Wang, Xingyun Xu, Zongbing Hao, Shun Zhang, Dan Wu, Hongyang Sun, Chenchen Mu, Haigang Ren, Guanghui Wang · 2019 · Neuroscience Bulletin
  74. Biological and methodological complexities of beta‐amyloid peptide: Implications for Alzheimer’s disease research
    Martyna M. Matuszyk, Claire J. Garwood, Laura Ferraiuolo, Julie E. Simpson, Rosemary A. Staniforth, Stephen B. Wharton · 2021 · Journal of Neurochemistry
  75. Tau proteinopathies and the prion concept
    2020 · Progress in Molecular Biology and Translational Science
  76. Roles of zinc ions and structural polymorphism of β-amyloid in the development of Alzheimer’s disease
    Alexandra A. Kulikova, Alexander А. Makarov, Sergey A. Kozin · 2015 · Molecular Biology
  77. Human prion diseases: Molecular, cellular and population biology
    Mark W. Head · 2013 · Neuropathology
  78. Phosphorylation at Ser8 as an Intrinsic Regulatory Switch to Regulate the Morphologies and Structures of Alzheimer's 40-residue β-Amyloid (Aβ40) Fibrils
    Zhiwen Hu, Meng-Rong Ma, Yong‐Xiang Chen, Yufen Zhao, Wei Qiang, Yanmei Li · 2016 · Journal of Biological Chemistry
  79. Infectious Alzheimer's disease?
    Roland Riek · 2006 · Nature
  80. “Prion-like” seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders
    Silvia Zampar, Sonja E. Di Gregorio, Gustavo Grimmer, Joel C. Watts, Martin Ingelsson · 2024 · Frontiers in Neuroscience
  81. Why therapies for Alzheimer’s disease do not work: Do we have consensus over the path to follow?
    Zareen Amtul · 2015 · Ageing Research Reviews
  82. From Prion Diseases to Prion-Like Propagation Mechanisms of Neurodegenerative Diseases
    Isabelle Acquatella-Tran Van Ba, Thibaut Imberdis, Véronique Perrier · 2013 · International Journal of Cell Biology
  83. Amyloid-β containing isoaspartate 7 as potential biomarker and drug target in Alzheimer's disease
    Sergey A. Kozin, Vladimir A. Mitkevich, Alexander А. Makarov · 2016 · Mendeleev Communications
  84. Amyloid pathology arrangements in Alzheimer’s disease brains modulate in vivo seeding capability
    Claudia A. Duran-Aniotz, Inés Moreno‐González, Nazaret Gamez, Nelson Perez-Urrutia, Laura Vegas‐Gomez, Claudio A. Soto, Rodrigo Morales · 2021 · Acta Neuropathologica Communications
  85. Transmissible spongiform encephalopathy in the 21st century
    Paul Brown · 2008 · Neurology
  86. Physical basis for the ofloxacin-induced acceleration of lysozyme aggregation and polymorphism in amyloid fibrils
    Shivani A. Muthu, Nivin Mothi, Sonali M. Shiriskar, Raghuvir R. S. Pissurlenkar, Anil Kumar, Basir Ahmad · 2016 · Archives of Biochemistry and Biophysics
  87. Dominant negative factors in health and disease
    Reiner A. Veitia · 2009 · The Journal of Pathology
  88. Prion-like Mechanisms in Alzheimer's Disease
    Ruihua Yin, Lan Tan, Teng Jiang, Jin‐Tai Yu · 2014 · Current Alzheimer Research
  89. Trans-Synaptic Spread of Amyloid-βin Alzheimer’s Disease: Paths toβ-Amyloidosis
    Annabella Pignataro, Silvia Middei · 2017 · Neural Plasticity
  90. Chemical and biophysical insights into the propagation of prion strains
    Jeppe Falsig, K. Peter R. Nilsson, Tuomas P. J. Knowles, Adriano Aguzzi · 2008 · HFSP journal
  91. Amyloid-β with isomerized Asp7 cytotoxicity is coupled to protein phosphorylation
    Olga G. Zatsepina, O. I. Kechko, Vladimir A. Mitkevich, Sergey A. Kozin, M. M. Yurinskaya, М. Г. Винокуров, Marina V. Serebryakova, Alexander P. Rezvykh, Michael B. Evgen’ev, Alexander А. Makarov · 2018 · Scientific Reports
  92. Bioassays and Inactivation of Prions
    Kurt Giles, Amanda L. Woerman, David B. Berry, Stanley B. Prusiner · 2017 · Cold Spring Harbor Perspectives in Biology
  93. Aβ seeds and prions: How close the fit?
    Jay Rasmussen, Mathias Jucker, Lary C. Walker · 2017 · Prion
  94. Alzheimer's disease under strain
    Adriano Aguzzi · 2014 · Nature
  95. Insights into Mechanisms of Chronic Neurodegeneration
    Abigail B. Diack, James D. Alibhai, Rona M. Barron, Barry Matthew Bradford, Pedro Piccardo, Jean C. Manson · 2016 · International Journal of Molecular Sciences
  96. Modified amyloid variants in pathological subgroups of β‐amyloidosis
    Janina Gerth, Sathish Kumar, Ajeet Rijal Upadhaya, Estifanos Ghebremedhin, Christine A. F. Von Arnim, Dietmar Rudolf Thal, Jochen Walter · 2018 · Annals of Clinical and Translational Neurology
  97. Transmission of cerebral amyloid pathology by peripheral administration of misfolded Aβ aggregates
    Rodrigo Morales, Javiera B Bravo-Alegria, Inés Moreno‐González, Claudia A. Duran-Aniotz, Nazaret Gamez, George A. Edwards, Claudio A. Soto · 2021 · Molecular Psychiatry
  98. Prion Disease: The Implications for Dentistry
    Amir Azarpazhooh, Edward D. Fillery · 2008 · Journal of Endodontics
  99. Amyloid-specific fluorophores for the rapid, sensitive in situ detection of prion contamination on surgical instruments
    I.P. Lipscomb, R. Hervé, Katherine Harris, H.E. Pinchin, R. Collin, Charles William Keevil · 2007 · Journal of General Virology
  100. TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY IN THE 21st CENTURY: NEUROSCIENCE FOR THE CLINICAL NEUROLOGIST
    Steven Robert Brenner · 2009 · Neurology